***Background.*** Patients with presumptive diagnoses of tick-borne illnesses, including babesiosis and anaplasmosis are often treated for both diseases given their similar presentations in the preliminary stages of illness. This delay may expose patients to the side-effects of unnecessary treatment. During the year 2013, our endemic region saw a substantial increase in tick-borne illnesses. The aim of this study is to compare the presenting complaints, physical examination findings, laboratory values, and comorbidities for patients diagnosed with anaplasmosis or babesiosisin during this time of peak disease activity.

***Methods.*** This cross-sectional study included patients with PCR-confirmed babesiosis or anaplasmosis diagnosed between January 1, 2013 and November 1, 2013. Data were collected from inpatient and outpatient electronic medical records. One-way analysis of variance was performed on continuous variables (age, duration of illness, laboratory data) and Fisher\'s Exact Test for categorical variables (sex, comorbidities, presenting signs/symptoms, Lyme disease coinfection). Statistical significance was assigned at p \< 0.05.

***Results.*** Of the 136 patients studied, 91 were diagnosed with anaplasmosis and 45 with babesiosis. Patients with anaplasmosis were statistically significantly more likely than those with babesiosis to present earlier to a physician or the ED following onset of symptoms (6.8 vs 4.2 days) and to have a lower serum sodium (136.4 vs 138.2), leukocyte count (4.5 vs 5.4), and total bilirubin (0.93 vs 1.40) on initial presentation. However, patients with babesiosis were significantly more likely to have a lower initial hemoglobin (12.0 vs 14.0) and hematocrit (35.1 vs 40.7), and a higher lactate dehydrogenase level (1794.5 vs 654.1). Patients with B. microti infection were significantly more likely to be coinfected with Borrelia burgdorferi compared with those infected with A. phagocytophilum (53.3% vs 7.7%), and to have a rash (15.6% vs 5.5%).

***Conclusion.*** Our study shows key differences in the initial presentation, history, and laboratory values between patients with babesiosis vs anaplasmosis. This information may help to narrow and expedite therapeutic choices for patients.
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